PhD defence by Camilla Thorlaksen
Investigation of Protein Aggregate Characteristics and their Contribution to Immunogenicity Risk
Assessment committee
(Chairperson) Associate Professor Annette Eva Langkilde, University of Copenhagen
Dr Eva Horn Møller, Zealand Pharma A/S
Professor Alessandro Sette, University of California, US
Supervisors
Associate Professor Vito Foderà, University of Copenhagen
Specialist Minna Grønning Jensen, Novo Nordisk A/S
Principal Scientist Christina Bartholdy, LEO Pharma
Associate Professor Nikos Hatzakis, University of Copenhagen
Specialist Martin Busch Neergaard, Novo Nordisk A/S
Principal Scientist Heidi Schultz, Dragonfly Therapeutics Aps
Professor Wim Jiskoot, Leiden University, the Netherlands
Department
Pharmacy
Graduate programme
Pharmaceutical Sciences
Place of study
The experimental work took place at Novo Nordisk A/S (CMC analytical support, biophysics team), Department of Pharmacy (Foderà group), University of Copenhagen, and at Leiden University (LACDR), the Netherlands
Place
Benzon Auditorium, Building 12, PharmaSchool, Universitetsparken 2, 2100, Copenhagen
Ask for a copy of the thesis
cdbt@novonordisk.com